3[1]Wallace H,Shorvon S,Tallis R.Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2 052 922 and age-specific fertility rates of women with epilepsy[J]. Lancet , 1998,352(19/26):1970.
4[2]Zahn C. Neurologic care of pregnant woman with epilepsy[J]. Epilepsia, 1998,39 (Suppl 8):S26.
5[3]Samren EB, Cornelia MVD, Chritiaens GCML, et al .Antiepileptic drug regimens and major congenital abnormalities in the offspring[J]. Ann Neurol, 1997,46(5):739.
6[4]Carla A, Sonia B, Elisapeth R, et al. Teratogenic effects of antiepileptic drugs: use of an international database on malformations and Drug Exposure(MADRE)[J]. Epilepsia, 2000,41(11):1436.
7[5]Wlodarczyk B, Biernacki B, Minta M. Teratogenic action of antiepileptic drug: 2-propylpentanoicacid effects on rat and hamster embryos caltured in vitro[J]. Ginekol Pol, 2001,72(12):955.
8[6]Stoler JM. Maternal antiepileptic drug use and effects on fetal development[J]. Curr Opin Pediatr, 2001, 13(6):566.
9[7]Lewis BH, Elizabeth AH, Brent AC, et al. The teratogenicty of anticonvulsant drugs[J]. N Engl J Med,2001,344(15):1132.
10[8]Canger R, Battino D, Canevini MP, et al. Malformation in offspring of woman with epilepsy: A prospective study[J]. Epilepsia, 1999,40(9):1231.
